Similar articles

• [Comparative evaluation of the antidepressive properties of opipramol, imipramine and placebo in neurotic depression].

  Tétreault L, Doucet P, Blanchet A, Bordeleau JM. Tétreault L, et al. Union Med Can. 1966 May;95(5):546-53. Union Med Can. 1966. PMID: 5326793 Clinical Trial. French. No abstract available.
• [Double-blind study of the antidepressive drugs (noxiptilin-imipramine)].

  Berner P, Guss H, Hofmann G, Kryspin-Exner K, Küfferle B. Berner P, et al. Arzneimittelforschung. 1971 May;21(5):638-40. Arzneimittelforschung. 1971. PMID: 4936793 Clinical Trial. German. No abstract available.
• Clinical efficacy of chlorpromazine-procyclidine combination, imipramine and placebo in depressive disorders.

  Fink M, Klein DF, Kramer JC. Fink M, et al. Psychopharmacologia. 1965 Jan 14;7(1):27-36. Psychopharmacologia. 1965. PMID: 5318921 Clinical Trial. No abstract available.
• A statistical review of controlled trials of imipramine and placebo in the treatment of depressive illnesses.

  Rogers SC, Clay PM. Rogers SC, et al. Br J Psychiatry. 1975 Dec;127:599-603. doi: 10.1192/bjp.127.6.599. Br J Psychiatry. 1975. PMID: 1104034 Review.
• The NIMH collaborative depression studies--a progress report.

  Raskin A. Raskin A. Psychopharmacol Bull. 1972 Jul;8(3):55-9. Psychopharmacol Bull. 1972. PMID: 4559524 Review. No abstract available.